XRPN on Nasdaq
Armada Acquisition Corp. II
Price unavailable
Last updated Oct 16, 2026.
Overview
$1.8MNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-09-30 |
|---|---|
| General and administrative costs | -$1.7M |
| Loss from operations | -$1.7M |
| Interest earned on cash and marketable securities held in Trust Account | $3.5M |
| Other income, net | $3.5M |
| Net income | $1.8M |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-09-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|
| Cash | $361.1K | ||
| Prepaid expenses | $50.1K | ||
| Prepaid insurance | $137.4K | ||
| Total current assets | $548.5K | ||
| Prepaid insurance long-term | $22.9K | ||
| Cash and marketable securities held in Trust Account | $234.6M | $231.2M | |
| TOTAL ASSETS | $235.2M | ||
| Accrued offering costs | $75.0K | ||
| Accrued expenses | $1.4M | ||
| Total current liabilities | $1.5M | ||
| Deferred professional fees | $37.6K | ||
| Deferred underwriting fee payable | $9.2M | ||
| TOTAL LIABILITIES | $10.7M | ||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at a redemption value of $10.20 per share | $234.6M | ||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding | $0 | ||
| Additional paid-in capital | $0 | ||
| Accumulated deficit | -$10.1M | ||
| Total Shareholders' Deficit | -$10.1M | ||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | $235.2M | ||
| Temporary equity shares outstanding | 23.0M shares | ||
| Temporary equity redemption price per share | $10.20 | ||
| Preferred stock par value | $0.00 | ||
| Preferred stock shares authorized | 1.0M shares | ||
| Preferred stock shares issued | 0 shares | ||
| Preferred stock shares outstanding | 0 shares | ||
| Common stock par value | $0.10 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-09-30 |
|---|---|
| Net income | $1.8M |
| Payment of formation costs through promissory note | $4.6K |
| Payment of operating costs through promissory note | $870 |
| Payment of operating costs through issuance of Class B ordinary shares | $25.0K |
| Interest earned on cash and marketable securities held in Trust Account | -$3.5M |
| Adjustment to accrued offering costs | -$5.0K |
| Prepaid expenses | $50.5K |
| Prepaid insurance | -$160.3K |
| Accrued expenses | $1.4M |
| Deferred professional fees | $37.6K |
| Net cash used in operating activities | -$349.4K |
| Investment of cash in Trust Account | -$231.2M |
| Net cash used in investing activities | -$231.2M |
| Proceeds from sale of Units, net of underwriting discounts paid | $225.4M |
| Proceeds from sale of Private Placements Warrants | $7.1M |
| Proceeds from promissory note - related party | $127.8K |
| Repayment of promissory note - related party | -$143.1K |
| Payment of offering costs | -$624.1K |
| Net cash provided by financing activities | $231.9M |
| Net Change in Cash | $361.1K |
| Offering costs included in accrued offering costs | $75.0K |
| Deferred offering costs paid through promissory note related party | $9.8K |
| Accretion of Class A ordinary shares to redemption value | $22.4M |
| Deferred offering costs applied to prepaid expenses | $100.6K |
Recent filings
- Oct 13, 20264
- Oct 13, 20264
- Oct 9, 202625-NSE
- Oct 5, 20268-K
- Oct 5, 2026425
- Oct 2, 2026425
- Oct 1, 20268-K
- Oct 1, 2026425
- Sep 17, 20268-K
- Sep 17, 2026425
- Aug 27, 2026DEFM14A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 202610-Q
- Aug 13, 2026425
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6